Skip to content

    Recently Viewed


      lede-What You Need to Know About Johnson & Johnson's 2020 Fourth-Quarter and Full-Year Earnings Report.png

      What you need to know about Johnson & Johnson’s 2020 fourth-quarter and full-year earnings report

      Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its consumer, pharmaceutical and medical devices businesses.

      Share Article
      share to

      Today, Johnson & Johnson shared its 2020 fourth-quarter and full-year earnings report.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broad-based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “We achieved notable financial and operational performance in 2020 despite the many challenges and uncertainties presented by the global pandemic,” says Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This is a true testament to the strength and resilience of our broad-based business and the dedication of our global Johnson & Johnson colleagues to deliver on our commitments to patients and customers. Our unbridled focus and ability enabled us to stay the course across our three business segments to advance breakthrough innovation. Simultaneously, we advanced our COVID-19 vaccine candidate and look forward to sharing Phase 3 data soon. Johnson & Johnson is poised for future strong performance as we work to continue delivering better health solutions for everyone, everywhere.”

      For more details about the company’s 2020 fourth-quarter and full-year results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.

      Johnson & Johnson 2020 4th Quarter and Full Year Earnings infographic

      Johnson & Johnson’s 2020 Earnings

      Read the earnings press release, which includes fourth-quarter and full-year financial data for 2020.

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.